Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Somatic mosaicism reveals clonal distributions of neocortical development

  • Breuss, Martin W.
  • NIMH Brain Somatic Mosaicism Network
  • Gleeson, Joseph G.
The structure of the human neocortex underlies species-specific traits and reflects intricate developmental programs. Here we sought to reconstruct processes that occur during early development by sampling adult human tissues. We analysed neocortical clones in a post-mortem human brain through a comprehensive assessment of brain somatic mosaicism, acting as neutral lineage recorders1,2. We combined the sampling of 25 distinct anatomic locations with deep whole-genome sequencing in a neurotypical deceased individual and confirmed results with 5 samples collected from each of three additional donors. We identified 259 bona fide mosaic variants from the index case, then deconvolved distinct geographical, cell-type and clade organizations across the brain and other organs. We found that clones derived after the accumulation of 90-200 progenitors in the cerebral cortex tended to respect the midline axis, well before the anterior-posterior or ventral-dorsal axes, representing a secondary hierarchy following the overall patterning of forebrain and hindbrain domains. Clones across neocortically derived cells were consistent with a dual origin from both dorsal and ventral cellular populations, similar to rodents, whereas the microglia lineage appeared distinct from other resident brain cells. Our data provide a comprehensive analysis of brain somatic mosaicism across the neocortex and demonstrate cellular origins and progenitor distribution patterns within the human brain., We thank the individuals who donate their bodies and tissues for the advancement of research; S. Lee, C. Zhu and I. Tang for feedback; D. Weinberger, J. Kleinman, T. Hyde and R. Narukar for the samples; and R. Sinkovits, A. Majumdar and S. Strande at the San Diego Supercomputer Center. Sequencing is supported by the Rady Children’s Institute for Genomic Medicine and the UCSD Institute for Genomic Medicine. M.W.B. was supported by an EMBO Long-Term Fellowship (no. ALTF 174-2015), the Marie Curie Actions of the European Commission (nos LTFCOFUND2013 and GA-2013-609409) and an Erwin Schrödinger Fellowship by the Austrian Science Fund (no. J 4197-B30). This study was supported by grants to J.G.G. from the Howard Hughes Medical Institute, NIMH (1U01 MH108898, R01 MH124890 and R21 AG070462), and to C.K.G. from NIA (RF1 AG061060-02, R01 AG056511-02, R01 NS096170-04), and the UC San Diego IGM Genomics Center (S10 OD026929). A.N. was supported by the UK Dementia Research Institute, which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research UK.
Repisalud
Publicación Artículo científico (JournalArticle)

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

  • Céspedes, Pablo F
  • Jainarayanan, Ashwin
  • Fernández-Messina, Lola
  • Valvo, Salvatore
  • Saliba, David G
  • Kurz, Elke
  • Kvalvaag, Audun
  • Chen, Lina
  • Ganskow, Charity
  • Colin-York, Huw
  • Fritzsche, Marco
  • Peng, Yanchun
  • Dong, Tao
  • Johnson, Errin
  • Siller-Farfán, Jesús A
  • Dushek, Omer
  • Sezgin, Erdinc
  • Peacock, Ben
  • Law, Alice
  • Aubert, Dimitri
  • Engledow, Simon
  • Attar, Moustafa
  • Hester, Svenja
  • Fischer, Roman
  • Sánchez-Madrid, Francisco
  • Dustin, Michael L
The immunological synapse is a molecular hub that facilitates the delivery of three activation signals, namely antigen, costimulation/corepression and cytokines, from antigen-presenting cells (APC) to T cells. T cells release a fourth class of signaling entities, trans-synaptic vesicles (tSV), to mediate bidirectional communication. Here we present bead-supported lipid bilayers (BSLB) as versatile synthetic APCs to capture, characterize and advance the understanding of tSV biogenesis. Specifically, the integration of juxtacrine signals, such as CD40 and antigen, results in the adaptive tailoring and release of tSV, which differ in size, yields and immune receptor cargo compared with steadily released extracellular vesicles (EVs). Focusing on CD40L+ tSV as model effectors, we show that PD-L1 trans-presentation together with TSG101, ADAM10 and CD81 are key in determining CD40L vesicular release. Lastly, we find greater RNA-binding protein and microRNA content in tSV compared with EVs, supporting the specialized role of tSV as intercellular messengers.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A critical re-evaluation of multilocus sequence typing (MLST) efforts in Wolbachia

  • Bleidorn, Christoph
  • Gerth, Michael
Wolbachia (Alphaproteobacteria, Rickettsiales) is the most common, and arguably one of the most important inherited symbionts. Molecular differentiation of Wolbachia strains is routinely performed with a set of five multilocus sequence typing (MLST) markers. However, since its inception in 2006, the performance of MLST in Wolbachia strain typing has not been assessed objectively. Here, we evaluate the properties of Wolbachia MLST markers and compare it to 252 other single copy loci present in the genome of most Wolbachia strains. Specifically, we investigated how well MLST performs at strain differentiation, at reflecting genetic diversity of strains, and as phylogenetic marker. We find that MLST loci are outperformed by other loci at all tasks they are currently employed for, and thus that they do not reflect the properties of a Wolbachia strain very well. We argue that whole genome typing approaches should be used for Wolbachia typing in the future. Alternatively, if few loci approaches are necessary, we provide a characterisation of 252 single copy loci for a number a criteria, which may assist in designing specific typing systems or phylogenetic studies., This work was supported by the Spanish Ministry of Science and Education (MEC) [RYC-2014–15615 to CB]; European Molecular Biology Organization [ALTF 48–2015 to MG]; and Marie-Curie Actions of the European Commission [LTFCOFUND2013, GA-2013–609409 to MG]., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Perturbed Redox Signaling Exacerbates a Mitochondrial Myopathy

  • Dogan, Sukru Anil
  • Cerutti, Raffaele
  • Benincá, Cristiane
  • Brea-Calvo, Gloria
  • Trevor Jacobs, Howard
  • Zeviani, Massimo
  • Szibor, Marten
  • Viscomi, Carlo
Alternative oxidases (AOXs) bypass respiratory complexes III and IV by transferring electrons from coenzyme Q directly to O2. They have therefore been proposed as a potential therapeutic tool for mitochondrial diseases. We crossed the severely myopathic skeletal muscle-specific COX15 knockout (KO) mouse with an AOX-transgenic mouse. Surprisingly, the double KO-AOX mutants had decreased lifespan and a substantial worsening of the myopathy compared with KO alone. Decreased ROS production in KO-AOX versus KO mice led to impaired AMPK/PGC-1α signaling and PAX7/MYOD-dependent muscle regeneration, blunting compensatory responses. Importantly, the antioxidant N-acetylcysteine had a similar effect, decreasing the lifespan of KO mice. Our findings have major implications for understanding pathogenic mechanisms in mitochondrial diseases and for the design of therapies, highlighting the benefits of ROS signaling and the potential hazards of antioxidant treatment., This work was supported by MRC-QQR Grant 2015-2020 (M.Z.), ERC Advanced Grants ERC FP7-322424 (M.Z.) and 232738 (H.T.J.), NRJ-Institut de France (M.Z.), and Academy of Finland grants 272376 and 256615 (H.T.J.). S.A.D. was supported by an EMBO Long-Term Fellowship (ALTF 856-2014) and EU (LTFCOFUND2013, GA-2013-609409). We are grateful to the personnel at ARES and Phenomics Animal Care Facilities for the support in managing our colonies. The BF-F3, SC-71, and BA-F8 monoclonal antibodies developed by Prof. Stefano Schiaffino, University of Padova, Italy, were obtained from the Developmental Studies Hybridoma Bank; created by the NICHD of the NIH; and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural and mechanistic insights into the catalytic-domain-mediated short-range glycosylation preferences of GalNAc-T4

  • Rivas, Matilde de las
  • Paul Daniel, Earnest James
  • Coelho, Helena
  • Lira-Navarrete, Erandi
  • Raich, Lluis
  • Compañón, Ismael
  • Diniz, Ana
  • Lagartera, Laura
  • Jiménez-Barbero, Jesús
  • Clausen, Henrik
  • Rovira, Carme
  • Marcelo, Filipa
  • Corzana, Francisco
  • Gerken, Thomas A.
  • Hurtado-Guerrero, Ramón
17 pags, 4 figs, 2 tabs, Mucin-type O-glycosylation is initiated by a family of polypeptide GalNAc-transferases (GalNAc-Ts) which are type-II transmembrane proteins that contain Golgi luminal catalytic and lectin domains that are connected by a flexible linker. Several GalNAc-Ts, including GalNAc-T4, show both long-range and short-range prior glycosylation specificity, governed by their lectin and catalytic domains, respectively. While the mechanism of the lectin-domain-dependent glycosylation is well-known, the molecular basis for the catalytic-domain-dependent glycosylation of glycopeptides is unclear. Herein, we report the crystal structure of GalNAc-T4 bound to the diglycopeptide GAT GAGAGAGT TPGPG (containing two α-GalNAc glycosylated Thr (T ), the PXP motif and a "naked" Thr acceptor site) that describes its catalytic domain glycopeptide GalNAc binding site. Kinetic studies of wild-type and GalNAc binding site mutant enzymes show the lectin domain GalNAc binding activity dominates over the catalytic domain GalNAc binding activity and that these activities can be independently eliminated. Surprisingly, a flexible loop protruding from the lectin domain was found essential for the optimal activity of the catalytic domain. This work provides the first structural basis for the short-range glycosylation preferences of a GalNAc-T., We thank synchrotron radiation sources DLS (Oxford) and in particular beamline I03 (experiment number MX10121-15). We thank ARAID, MEC (CTQ2013-44367-C2-2-P, BFU2016-75633-P, CTQ2015-67727-R, CTQ2015-70524-R, and CTQ2017-85496-P), AGAUR (SGR2017-1189), the National Institutes of Health (R01-GM113534, and instrument Grant GM113534-01S to T. A. Gerken), the Danish National Research Foundation (DNRF107), the FCT-Portugal [UID/Multi/04378/2013 cofinanced by the FEDER (POCI- 01-0145-FEDER-007728)], and the DGA (E34_R17) for financial support. I. Compañón thanks Universidad de La Rioja for the FPI grant. F. Marcelo thanks FCT-Portugal for IF Investigator grant (IF/00780/2015) and PTNMR supported by Project 022161. E. Lira-Navarrete acknowledges her postdoctoral EMBO fellowship ALTF 1553-2015 cofunded by the European Commission (LTFCOFUND2013, GA-2013-609409) and Marie Curie Actions. H. Coelho and J. Jiménez-Barbero thank EU for the TOLLerant project. The research leading to these results has also received funding from the FP7 (2007−2013) under BioStruct-X (Grant agreement 283570 and BIOSTRUCTX_5186). We would also like to acknowledge the assistance of Juwan Lee in obtaining the GalNAc-T4 random peptide motifs
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural snalysis of a GalNAc-T2 mutant reveals an induced-fit catalytic mechanism for GalNAc-Ts

  • Rivas, Matilde de las
  • Coelho, Helena
  • Diniz, Ana
  • Lira-Navarrete, Erandi
  • Compañón, Ismael
  • Jiménez-Barbero, Jesús
  • Schjoldager, Katrine T.
  • Bennett, Eric P.
  • Vakhrushev, Sergey Y.
  • Clausen, Henrik
  • Corzana, Francisco
  • Marcelo, Filipa
  • Hurtado-Guerrero, Ramón
11 pags, 8 figs, The family of polypeptide N-acetylgalactosamine (GalNAc) transferases (GalNAc-Ts) orchestrates the initiating step of mucin-type protein O-glycosylation by transfer of GalNAc moieties to serine and threonine residues in proteins. Deficiencies and dysregulation of GalNAc-T isoenzymes are related to different diseases. Recently, it has been demonstrated that an inactive GalNAc-T2 mutant (F104S), which is not located at the active site, induces low levels of high-density lipoprotein cholesterol (HDL-C) in humans. Herein, the molecular basis for F104S mutant inactivation has been deciphered. Saturation transfer difference NMR spectroscopy experiments demonstrate that the mutation induces loss of binding to peptide substrates. Analysis of the crystal structure of the F104S mutant bound to UDP-GalNAc (UDP=uridine diphosphate), combined with molecular dynamics (MD) simulations, has revealed that the flexible loop is disordered and displays larger conformational changes in the mutant enzyme than that in the wild-type (WT) enzyme. 19F NMR spectroscopy experiments reveal that the WT enzyme only reaches the active state in the presence of UDP-GalNAc, which provides compelling evidence that GalNAc-T2 adopts a UDP-GalNAc-dependent induced-fit mechanism. The F104S mutation precludes the enzyme from achieving the active conformation and concomitantly binding peptide substrates. This study provides new insights into the catalytic mechanism of the large family of GalNAc-Ts and how these enzymes orchestrate protein O-glycosylation., We thank the Ministerio de Economia y Competitividad (CTQ2013-44367-C2-2-P and BFU2016-75633-P to R.H-G., CTQ2015-67727-R to F.C., CTQ2015-64597-C2-1P to J.J-B). F.M. thanks FCT-Portugal for the IF project (IF/00780/2015) and UCIBIO funding UID/Multi/04378/2013 cofinanced by the FEDER (POCI-01-0145-FEDER-007728). The NMR spectrometers are part of PTNMR supported by project no. 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC). H.C. thanks the Lundbeck Foundation and the Danish National Research Foundation (DNRF107). E.L-N. acknowledges her postdoctoral EMBO fellowship ALTF 1553-2015 cofunded by the European Commission (LTFCO-FUND2013, GA-2013-609409) and Marie Curie Actions. H.C. and J.J-B. thank the EU for the TOLLerant project. R.H-G. thanks the Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) and the Diputacion General de Aragon (DGA, B89) for financial support. Research leading to these results has also received funding from the FP7 (2007-2013) under BioStruct-X (grant agreement no. 283570 and BIOSTRUCTX_5186). We thank synchrotron radiation source DIAMOND (Oxford) and beamline I04 (number of experiment MX10121-19). We would also like to thank to Prof. Tom Gerken for his valuable comments on our manuscript., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences

  • Rivas, M.D.L.
  • Lira-Navarrete, E.
  • Daniel, E.J.P.
  • Companõn, I.
  • Coelho, H.
  • Diniz, A.
  • Jiménez-Barbero, J.
  • Peregrina, J.M.
  • Clausen, H.
  • Corzana, F.
  • Marcelo, F.
  • Jiménez-Osés, G.
  • Gerken, T.A.
  • Hurtado-Guerrero, R.
The polypeptide GalNAc-transferases (GalNAc-Ts), that initiate mucin-type O-glycosylation, consist of a catalytic and a lectin domain connected by a flexible linker. In addition to recognizing polypeptide sequence, the GalNAc-Ts exhibit unique long-range N- A nd/or C-terminal prior glycosylation (GalNAc-O-Ser/Thr) preferences modulated by the lectin domain. Here we report studies on GalNAc-T4 that reveal the origins of its unique N-terminal long-range glycopeptide specificity, which is the opposite of GalNAc-T2. The GalNAc-T4 structure bound to a monoglycopeptide shows that the GalNAc-binding site of its lectin domain is rotated relative to the homologous GalNAc-T2 structure, explaining their different long-range preferences. Kinetics and molecular dynamics simulations on several GalNAc-T2 flexible linker constructs show altered remote prior glycosylation preferences, confirming that the flexible linker dictates the rotation of the lectin domain, thus modulating the GalNAc-Ts'' long-range preferences. This work for the first time provides the structural basis for the different remote prior glycosylation preferences of the GalNAc-Ts.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

A perspective on structural and mechanistic aspects of protein O-fucosylation

  • Lira-Navarrete, E.
  • Hurtado-Guerrero, R.
Protein O-fucosylation is an important post-translational modification (PTM) found in cysteine-rich repeats in proteins. Protein O-fucosyltransferases 1 and 2 (PoFUT1 and PoFUT2) are the enzymes responsible for this PTM and selectively glycosylate specific residues in epidermal growth factor-like (EGF) repeats and thrombospondin type I repeats (TSRs), respectively.Within the past six years, crystal structures of both enzymes have been reported, revealing important information on how they recognize protein substrates and achieve catalysis. Here, the structural information available today is summarized and how PoFUT1 and PoFUT2 employ different catalytic mechanisms is discussed.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Structural Analysis of a GalNAc-T2 Mutant Reveals an Induced-Fit Catalytic Mechanism for GalNAc-Ts

  • de las Rivas, M.
  • Coelho, H.
  • Diniz, A.
  • Lira-Navarrete, E.
  • Compañón, I.
  • Jiménez-Barbero, J.
  • Schjoldager, K.T.
  • Bennett, E.P.
  • Vakhrushev, S.Y.
  • Clausen, H.
  • Corzana, F.
  • Marcelo, F.
  • Hurtado-Guerrero, R.
The family of polypeptide N-acetylgalactosamine (GalNAc) transferases (GalNAc-Ts) orchestrates the initiating step of mucin-type protein O-glycosylation by transfer of GalNAc moieties to serine and threonine residues in proteins. Deficiencies and dysregulation of GalNAc-T isoenzymes are related to different diseases. Recently, it has been demonstrated that an inactive GalNAc-T2 mutant (F104S), which is not located at the active site, induces low levels of high-density lipoprotein cholesterol (HDL-C) in humans. Herein, the molecular basis for F104S mutant inactivation has been deciphered. Saturation transfer difference NMR spectroscopy experiments demonstrate that the mutation induces loss of binding to peptide substrates. Analysis of the crystal structure of the F104S mutant bound to UDP-GalNAc (UDP=uridine diphosphate), combined with molecular dynamics (MD) simulations, has revealed that the flexible loop is disordered and displays larger conformational changes in the mutant enzyme than that in the wild-type (WT) enzyme. 19F NMR spectroscopy experiments reveal that the WT enzyme only reaches the active state in the presence of UDP-GalNAc, which provides compelling evidence that GalNAc-T2 adopts a UDP-GalNAc-dependent induced-fit mechanism. The F104S mutation precludes the enzyme from achieving the active conformation and concomitantly binding peptide substrates. This study provides new insights into the catalytic mechanism of the large family of GalNAc-Ts and how these enzymes orchestrate protein O-glycosylation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Identification of global inhibitors of cellular glycosylation

  • Madriz Sørensen, D.
  • Büll, C.
  • Madsen, T. D.
  • Lira-Navarrete, E.
  • Clausen, T. M.
  • Clark, A. E.
  • Garretson, A. F.
  • Karlsson, R.
  • Pijnenborg, J. F. A.
  • Yin, X.
  • Miller, R. L.
  • Chanda, S. K.
  • Boltje, T. J.
  • Schjoldager, K. T.
  • Vakhrushev, S. Y.
  • Halim, A.
  • Esko, J. D.
  • Carlin, A. F.
  • Hurtado-Guerrero, R.
  • Weigert, R.
  • Clausen, H.
  • Narimatsu, Y.
Small molecule inhibitors of glycosylation enzymes are valuable tools for dissecting glycan functions and potential drug candidates. Screening for inhibitors of glycosyltransferases are mainly performed by in vitro enzyme assays with difficulties moving candidates to cells and animals. Here, we circumvent this by employing a cell-based screening assay using glycoengineered cells expressing tailored reporter glycoproteins. We focused on GalNAc-type O-glycosylation and selected the GalNAc-T11 isoenzyme that selectively glycosylates endocytic low-density lipoprotein receptor (LDLR)-related proteins as targets. Our screen of a limited small molecule compound library did not identify selective inhibitors of GalNAc-T11, however, we identify two compounds that broadly inhibited Golgi-localized glycosylation processes. These compounds mediate the reversible fragmentation of the Golgi system without affecting secretion. We demonstrate how these inhibitors can be used to manipulate glycosylation in cells to induce expression of truncated O-glycans and augment binding of cancer-specific Tn-glycoprotein antibodies and to inhibit expression of heparan sulfate and binding and infection of SARS-CoV-2.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Somatic mosaicism reveals clonal distributions of neocortical development

  • Breuss, Martin W.
  • NIMH Brain Somatic Mosaicism Network
  • Gleeson, Joseph G.
The structure of the human neocortex underlies species-specific traits and reflects intricate developmental programs. Here we sought to reconstruct processes that occur during early development by sampling adult human tissues. We analysed neocortical clones in a post-mortem human brain through a comprehensive assessment of brain somatic mosaicism, acting as neutral lineage recorders1,2. We combined the sampling of 25 distinct anatomic locations with deep whole-genome sequencing in a neurotypical deceased individual and confirmed results with 5 samples collected from each of three additional donors. We identified 259 bona fide mosaic variants from the index case, then deconvolved distinct geographical, cell-type and clade organizations across the brain and other organs. We found that clones derived after the accumulation of 90-200 progenitors in the cerebral cortex tended to respect the midline axis, well before the anterior-posterior or ventral-dorsal axes, representing a secondary hierarchy following the overall patterning of forebrain and hindbrain domains. Clones across neocortically derived cells were consistent with a dual origin from both dorsal and ventral cellular populations, similar to rodents, whereas the microglia lineage appeared distinct from other resident brain cells. Our data provide a comprehensive analysis of brain somatic mosaicism across the neocortex and demonstrate cellular origins and progenitor distribution patterns within the human brain., We thank the individuals who donate their bodies and tissues for the advancement of research; S. Lee, C. Zhu and I. Tang for feedback; D. Weinberger, J. Kleinman, T. Hyde and R. Narukar for the samples; and R. Sinkovits, A. Majumdar and S. Strande at the San Diego Supercomputer Center. Sequencing is supported by the Rady Children’s Institute for Genomic Medicine and the UCSD Institute for Genomic Medicine. M.W.B. was supported by an EMBO Long-Term Fellowship (no. ALTF 174-2015), the Marie Curie Actions of the European Commission (nos LTFCOFUND2013 and GA-2013-609409) and an Erwin Schrödinger Fellowship by the Austrian Science Fund (no. J 4197-B30). This study was supported by grants to J.G.G. from the Howard Hughes Medical Institute, NIMH (1U01 MH108898, R01 MH124890 and R21 AG070462), and to C.K.G. from NIA (RF1 AG061060-02, R01 AG056511-02, R01 NS096170-04), and the UC San Diego IGM Genomics Center (S10 OD026929). A.N. was supported by the UK Dementia Research Institute, which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research UK.